Phase I trial (QSC303813)

  • Research type

    Research Study

  • Full title

    Publication of this data is currently deferred.

  • IRAS ID

    1014302

  • Contact name

    Kerstin Lösel

  • Contact email

    kerstin.losel@astrazeneca.com

  • Sponsor organisation

    Publication of this data is currently deferred.

  • Clinicaltrials.gov Identifier

    NCT07911514

  • Research summary

    Publication of this data is currently deferred.

  • REC name

    HSC REC A

  • REC reference

    26/NI/0093

  • Date of REC Opinion

    2 Oct 2026

  • REC opinion

    Further Information Favourable Opinion